Clinical Trial Update: 3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing adjuvated reduced-dose IPV-aluminum SSI and non-adjuvated full-dose IPV-SSI as primary vaccinations in infants for poliomyeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• IPV-SSI (inactivated poliovirus vaccine)
• IPV-al SSI (inactivated poliovirus vaccine)

Snippet

Sponsor: Statens Serum Institut | Conditions: Poliomyelitis | Phase 2 | Status: COMPLETED